Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Центральный несахарный диабет: существует ли эффективное решение проблемы?
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Aoyagi T, Koshimizu TA, Tanoue A. Vasopressin regulation of blood pressure and volume: findings from V1a receptor-deficient mice. Kidney Int 2009; 76(10): 1035–9.
2. Baylis PH, Cheettham T. Diabetes insipidus. Arch Dis Child 1998; 79: 84–9.
3. Baylis PH, Thompson CJ. Osmoregulation of vasopressin secretion and thirst in health and disease. Clin Endocrinol (Oxf) 1988; 29 (5): 549–76.
4. Ball SG. Vasopressin and disorders of water balance: the physiology and pathophysiology. Ann Clin Biochem 2007; 44: 417–31.
5. Callreus T, Lundahl J, Hoglund P, Bengtsson P. Changes in gastrointestinal motility influence the absorption of desmopressin. Eur J Clin Pharmacol 1999; 55 (4): 305–9.
6. Carraro A, Fano M, Porcella E et al. Treatment of central diabetes insipidus using oral DDAVP. Comparison with intranasal treatment. Minerva Endocrinol 1991; 16(3): 141–5.
7. Clements JA, Funder JW. Arginine Vasopressin (AVP) and AVP-like immunoreactivity in peripheral tissues. Endocrin Rev 1986; 7: 449–60.
8. Durr JA. Diabetes insipidus in pregnancy. Am J Kidney Dis 1987; 9: 276–83.
9. Kim RJ, Malattia C, Allen M et al. Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations. Pediatr Endocrinol Rev 2004; 2 (Suppl 1): 115–23.
10. Laczi F. Diabetes insipidus: etiology, diagnosis, and therapy. Orv Hetil 2002; 143 (46): 2579–85.
11. Maghnie M. Diabetes insipidus. Horm Res 2003; 59 (Suppl.): 142–54.
12. Mendoza MF, Cоrdenas TH, Montero GP, Bravo RL Desmopressin tablets in treatment of patients with central diabetes insipidus. Cir Ciruj 2002; 70 (2): 93–7.
13. Nemergut EC. Predictors of diabetes insipidus after transsphenoidal surgery: a review of 881 patients. J Neurosurg 2005; 103: 448–54.
14. Nielsen S, Frokiaer J, Marples D et al. Aquaporins in the kidney: from molecules to medicine. Physiol Rev 2002; 82: 205–44.
15. Pivonello R, De Bellis A, Faggiano A et al. Central diabetes insipidus and autoimmunity: relationship between the occurrence of antibodies to arginine vasopressin-secreting cells and clinical, immunological, and radiological features in a large cohort of patients with central diabetes insipidus of known and unknown etiology. J Clin Endocrinol Metab 2003; 88(4): 1629–36.
16. Prager-Khoutorsky M, Bourque CW. Osmosensation in vasopressin neurons: changing actin density to optimize function. Trends Neurosci 2010; 33 (2): 76–83.
17. Robinson AG, Verbalis JG. The posterior pituitary. In Williams Textbook of Endocrinology; Philadelphia, 2003: WB Saunders; 281–329.
18. Robertson GL, Shelton RL, Athar S. The osmoregulation of vasopressin. Kidney Int. 1976; 10(1): 25–37.
19. Robertson GL .Thirst and vasopressin function in normal and disordered states of water balance. J Lab Clin Med 1983; 101: 351–71.
20. Sands JM, Layton HE. The physiology of urinary concentration: an update. Semin Nephrol 2009; 29 (3): 178–95.
21. Tien R. MR imaging of the brain in patients with diabetes insipidus. Am J Neuroradiol 1991; 12: 533–42.
22. Vande Walle J, Stockner M, Raes A, Norgaard JP. Desmopressin 30 years in clinical use: a safety review. Curr Drug Saf 2007; 2 (3): 232–8.
23. Verbalis JG. Diabetes insipidus. Rev Endocr Metab Disord 2003; 4: 177–85.
2. Baylis PH, Cheettham T. Diabetes insipidus. Arch Dis Child 1998; 79: 84–9.
3. Baylis PH, Thompson CJ. Osmoregulation of vasopressin secretion and thirst in health and disease. Clin Endocrinol (Oxf) 1988; 29 (5): 549–76.
4. Ball SG. Vasopressin and disorders of water balance: the physiology and pathophysiology. Ann Clin Biochem 2007; 44: 417–31.
5. Callreus T, Lundahl J, Hoglund P, Bengtsson P. Changes in gastrointestinal motility influence the absorption of desmopressin. Eur J Clin Pharmacol 1999; 55 (4): 305–9.
6. Carraro A, Fano M, Porcella E et al. Treatment of central diabetes insipidus using oral DDAVP. Comparison with intranasal treatment. Minerva Endocrinol 1991; 16(3): 141–5.
7. Clements JA, Funder JW. Arginine Vasopressin (AVP) and AVP-like immunoreactivity in peripheral tissues. Endocrin Rev 1986; 7: 449–60.
8. Durr JA. Diabetes insipidus in pregnancy. Am J Kidney Dis 1987; 9: 276–83.
9. Kim RJ, Malattia C, Allen M et al. Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations. Pediatr Endocrinol Rev 2004; 2 (Suppl 1): 115–23.
10. Laczi F. Diabetes insipidus: etiology, diagnosis, and therapy. Orv Hetil 2002; 143 (46): 2579–85.
11. Maghnie M. Diabetes insipidus. Horm Res 2003; 59 (Suppl.): 142–54.
12. Mendoza MF, Cоrdenas TH, Montero GP, Bravo RL Desmopressin tablets in treatment of patients with central diabetes insipidus. Cir Ciruj 2002; 70 (2): 93–7.
13. Nemergut EC. Predictors of diabetes insipidus after transsphenoidal surgery: a review of 881 patients. J Neurosurg 2005; 103: 448–54.
14. Nielsen S, Frokiaer J, Marples D et al. Aquaporins in the kidney: from molecules to medicine. Physiol Rev 2002; 82: 205–44.
15. Pivonello R, De Bellis A, Faggiano A et al. Central diabetes insipidus and autoimmunity: relationship between the occurrence of antibodies to arginine vasopressin-secreting cells and clinical, immunological, and radiological features in a large cohort of patients with central diabetes insipidus of known and unknown etiology. J Clin Endocrinol Metab 2003; 88(4): 1629–36.
16. Prager-Khoutorsky M, Bourque CW. Osmosensation in vasopressin neurons: changing actin density to optimize function. Trends Neurosci 2010; 33 (2): 76–83.
17. Robinson AG, Verbalis JG. The posterior pituitary. In Williams Textbook of Endocrinology; Philadelphia, 2003: WB Saunders; 281–329.
18. Robertson GL, Shelton RL, Athar S. The osmoregulation of vasopressin. Kidney Int. 1976; 10(1): 25–37.
19. Robertson GL .Thirst and vasopressin function in normal and disordered states of water balance. J Lab Clin Med 1983; 101: 351–71.
20. Sands JM, Layton HE. The physiology of urinary concentration: an update. Semin Nephrol 2009; 29 (3): 178–95.
21. Tien R. MR imaging of the brain in patients with diabetes insipidus. Am J Neuroradiol 1991; 12: 533–42.
22. Vande Walle J, Stockner M, Raes A, Norgaard JP. Desmopressin 30 years in clinical use: a safety review. Curr Drug Saf 2007; 2 (3): 232–8.
23. Verbalis JG. Diabetes insipidus. Rev Endocr Metab Disord 2003; 4: 177–85.
Авторы
Е.В. Бирюкова
Московский государственный медико-стоматологический университет
Московский государственный медико-стоматологический университет
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.